bigger Created with Sketch.

Our mission is focused on curing disease and transforming patients’ lives

Learn About Our Technology

Our mission is focused on curing disease and transforming patients’ lives

Learn About Our Technology

Creating a Hopeful Reality

“This is powerful technology. It’s the iteration of over 100 years of work that has been done to define what a gene is and what it does, and now we can finally use that information to work to cure severe genetic disorders.”

Arthur Tzianabos, Ph.D.
Chief Executive Officer

Leaders in Genetic
Medicines

Homology Medicines has a broad, powerful and proprietary gene editing and gene therapy platform, an experienced and dedicated team and a commitment to bring new treatments and cures forward for the rare disease community.

Meet our Team

Recent News

06/16/2019
Homology Medicines Presents Data Showing Single Dose HMI-102 Resulted in Long-Term Correction of PKU, Including Reduction of Phe and Increased Brain Neurotransmitters in Murine Model ​
06/13/2019
Homology Medicines to Present at JMP Securities Life Sciences Conference​
06/10/2019
Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU and Expects Initial Clinical Results by Year End 2019​
VIEW ALL NEWS

“We have the opportunity now not just to treat patients but to potentially cure them.”

Albert Seymour, Ph.D.
Chief Scientific Officer